Effect of dipeptidyl peptidase-4 inhibitors on tumor necrosis factor alpha levels in patients with type 2 diabetes mellitus
Abstract Aims Dipeptidyl peptidase-4 inhibitors (DPP-4i) served as oral antidiabetic agents for treatment of type 2 diabetes mellitus (T2DM). Although an action on glucose homeostasis was identified, no well-rounded illustration had been established on the changes of tumor necrosis factor alpha (TNF...
Gardado en:
| Principais autores: | , , , , , , , |
|---|---|
| Formato: | Artigo |
| Idioma: | Inglês |
| Publicado: |
BMC
2024-07-01
|
| Series: | European Journal of Medical Research |
| Assuntos: | |
| Acceso en liña: | https://doi.org/10.1186/s40001-024-01955-9 |
| Tags: |
Sen Etiquetas, Sexa o primeiro en etiquetar este rexistro!
|